PathosMind by Pathos Communications Highlights Six Influential Leaders

By scanning more than 50,000 news publishers globally each day and analysing discussions across a worldwide network of ...
Yahoo Finance

Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief ...
Crain's Chicago Business

Tempus exec-founded biotech startup raises $62 million

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI, an artificial intelligence-powered drug ...
Crain's Chicago Business

Tempus execs are behind a new drug discovery startup

Two Tempus executives, including serial entrepreneur and billionaire Eric Lefkofsky, are behind a new drug discovery company in Chicago that's looking to raise $40 million. The startup, called Pathos ...
pharmaphorum

Pathos AI

Our round-up of recent biotech financings includes rounds for Pathos AI, Stylus Medicine, Haya Therapeutics, Therini Bio and Tiltbio. AstraZeneca has started work with Tempus and Pathos AI on a $200m ...